Advertisement

Topics

Astralis Ltd. Company Profile

04:18 EDT 22nd September 2017 | BioPortfolio

In January 2004, Astralis Ltd received its first patent from the United States Patent Office. This achievement has resulted from the quality and focus of our therapeutic research and development. Astralis intends to continue its growth through discovery and development of its own innovative products. "Strategic partnerships" will allow the company to develop and commercialize its products more efficiently and effectively.
Astralis is dedicated to developing novel treatments for immune system disorders and skin diseases. The company's products and development programs address a variety of key medical needs in areas such as dermatology and rheumatology.

The company has one product in clinical development, and has pre-clinical focus in areas including eczema, rheumatoid arthritis, and leishmaniasis. PSORAXINE®, for the treatment of moderate to severe psoriasis is currently in Phase II clinical trials.

The company's capabilities and capacity for protein manufacturing are also first-rate in quality. The company has established both its corporate headquarters and an R&D facility in New Jersey. The lab facility was renovated to include a state-of-the-art production area for Phase I and Phase II clinical supplies, as well as a fully equipped research and development area. We are committed to excellence in our development of cutting-edge products.

Location

75 Passaic Ave.
Fairfield
07004
United States of America

Contact

Phone: (973) 227-7168
Fax: (973) 227-7169
Email: info@astralisltd.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

10 Years Evaluation of Composite Restoration

This randomised, split-mouth clinical study evaluated the marginal quality of direct Class I and Class II restorations made of microhybrid composite and applied using two polymerisation pr...

Companies [1 Associated Companies listed on BioPortfolio]

Astralis Ltd.

In January 2004, Astralis Ltd received its first patent from the United States Patent Office. This achievement has resulted from the quality and focus of our therapeutic research and development. Astr...

More Information about "Astralis Ltd." on BioPortfolio

We have published hundreds of Astralis Ltd. news stories on BioPortfolio along with dozens of Astralis Ltd. Clinical Trials and PubMed Articles about Astralis Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Astralis Ltd. Companies in our database. You can also find out about relevant Astralis Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record